Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Serotonin transporter gene polymorphism as a predictor of short-term risk of suicide reattempts.

Daray FM, Arena ÁR, Armesto AR, Rodante DE, Puppo S, Vidjen P, Portela A, Grendas LN, Errasti AE.

Eur Psychiatry. 2018 Oct;54:19-26. doi: 10.1016/j.eurpsy.2018.07.001. Epub 2018 Jul 20.

PMID:
30036761
2.

CD207+CD1a+ cells circulate in pediatric patients with active Langerhans cell histiocytosis.

Carrera Silva EA, Nowak W, Tessone L, Olexen CM, Ortiz Wilczyñski JM, Estecho IG, Elena G, Errasti AE, Rosso DA.

Blood. 2017 Oct 26;130(17):1898-1902. doi: 10.1182/blood-2017-05-782730. Epub 2017 Aug 28.

3.

Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi.

Reigada C, Valera-Vera EA, Sayé M, Errasti AE, Avila CC, Miranda MR, Pereira CA.

PLoS Negl Trop Dis. 2017 Mar 17;11(3):e0005472. doi: 10.1371/journal.pntd.0005472. eCollection 2017 Mar.

4.

Involvement of Extracellular Signal-Regulated Kinase 5 in Kinin B1 Receptor Upregulation in Isolated Human Umbilical Veins.

Kilstein Y, Nowak W, Errasti AE, Feás AA, Armesto AR, Pelorosso FG, Rothlin RP.

J Pharmacol Exp Ther. 2016 Apr;357(1):114-24. doi: 10.1124/jpet.115.230169. Epub 2016 Jan 14.

PMID:
26769916
5.

MERTK as negative regulator of human T cell activation.

Cabezón R, Carrera-Silva EA, Flórez-Grau G, Errasti AE, Calderón-Gómez E, Lozano JJ, España C, Ricart E, Panés J, Rothlin CV, Benítez-Ribas D.

J Leukoc Biol. 2015 Apr;97(4):751-60. doi: 10.1189/jlb.3A0714-334R. Epub 2015 Jan 26.

6.

Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastoma.

Kusne Y, Carrera-Silva EA, Perry AS, Rushing EJ, Mandell EK, Dietrich JD, Errasti AE, Gibbs D, Berens ME, Loftus JC, Hulme C, Yang W, Lu Z, Aldape K, Sanai N, Rothlin CV, Ghosh S.

Sci Signal. 2014 Aug 12;7(338):ra75. doi: 10.1126/scisignal.2005196.

7.

T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response.

Carrera Silva EA, Chan PY, Joannas L, Errasti AE, Gagliani N, Bosurgi L, Jabbour M, Perry A, Smith-Chakmakova F, Mucida D, Cheroutre H, Burstyn-Cohen T, Leighton JA, Lemke G, Ghosh S, Rothlin CV.

Immunity. 2013 Jul 25;39(1):160-70. doi: 10.1016/j.immuni.2013.06.010. Epub 2013 Jul 11.

8.

[Pharmacogenetics in psychiatry: how far are we from clinical application?].

Daray FM, Maffia PC, Rothlin RP, Errasti AE.

Vertex. 2012 Jul-Aug;23(104):299-309. Review. Spanish.

PMID:
23170302
9.

EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin.

Sakariassen KS, Femia EA, Daray FM, Podda GM, Razzari C, Pugliano M, Errasti AE, Armesto AR, Nowak W, Alberts P, Meyer JP, Sorensen AS, Cattaneo M, Rothlin RP.

Thromb Res. 2012 Nov;130(5):746-52. doi: 10.1016/j.thromres.2012.08.309. Epub 2012 Sep 5.

PMID:
22959706
10.

Endothelial angiotensin-converting enzyme and neutral endopeptidase in isolated human umbilical vein: an effective bradykinin inactivation pathway.

Nowak W, Errasti AE, Armesto AR, Santín Velazque NL, Rothlin RP.

Eur J Pharmacol. 2011 Sep 30;667(1-3):271-7. doi: 10.1016/j.ejphar.2011.05.045. Epub 2011 Jun 1.

PMID:
21651905
11.

Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.

Errasti AE, del-Rey G, Cesio CE, Souza G, Nowak W, Pelorosso FG, Daray FM, Rothlin RP.

Eur J Pharmacol. 2009 May 21;610(1-3):68-74. doi: 10.1016/j.ejphar.2009.03.022. Epub 2009 Mar 14.

PMID:
19289115
12.

The endocannabinoid anandamide inhibits kinin B1 receptor sensitization through cannabinoid CB1 receptor stimulation in human umbilical vein.

Pelorosso FG, Gago JE, Del Rey G, Menéndez SD, Errasti AE, Rothlin RP.

Eur J Pharmacol. 2009 Jan 5;602(1):176-9. doi: 10.1016/j.ejphar.2008.10.058. Epub 2008 Nov 11.

PMID:
19022239
13.

Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein.

Nowak W, Goldschmidt ED, Falcioni AG, Pugliese MI, Errasti AE, Pelorosso FG, Daray FM, Gago JE, Rothlin RP.

Naunyn Schmiedebergs Arch Pharmacol. 2007 May;375(3):221-9. Epub 2007 Mar 20.

PMID:
17372720
14.

Potentiation of adrenaline vasoconstrictor response by sub-threshold concentrations of U-46619 in human umbilical vein: involvement of smooth muscle prostanoid TP(alpha) receptor isoform.

Errasti AE, Luciani LI, Cesio CE, Tramontano J, Boveris D, Daray FM, Nowak W, Pelorosso FG, Rothlin RP.

Eur J Pharmacol. 2007 May 21;562(3):227-35. Epub 2007 Feb 15.

PMID:
17362923
15.

Neutral endopeptidase up-regulation in isolated human umbilical artery: involvement in desensitization of bradykinin-induced vasoconstrictor effects.

Pelorosso FG, Halperin AV, Palma AM, Nowak W, Errasti AE, Rothlin RP.

J Pharmacol Exp Ther. 2007 Feb;320(2):713-20. Epub 2006 Nov 3.

PMID:
17085545
16.

Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein.

Daray FM, Colombo JR, Kibrik JR, Errasti AE, Pelorosso FG, Nowak W, Cracowski JL, Rothlin RP.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Aug;373(5):367-75.

PMID:
16738877
17.

Human umbilical vein vasoconstriction induced by epinephrine acting on alpha1B-adrenoceptor subtype.

Errasti AE, Werneck de Avellar MC, Daray FM, Tramontano J, Luciani LI, Lina Bard MJ, Maróstica E, Rothlin RP.

Am J Obstet Gynecol. 2003 Nov;189(5):1472-80.

PMID:
14634588
18.

Human umbilical vein: involvement of cyclooxygenase-2 pathway in bradykinin B1 receptor-sensitized responses.

Errasti AE, Rey-Ares V, Daray FM, Rogines-Velo MP, Sardi SP, Paz C, Podestá EJ, Rothlin RP.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Aug;364(2):149-56.

PMID:
11534854
19.

Bradykinin B1 receptor in isolated human umbilical vein: an experimental model of the in vitro up-regulation process.

Sardi SP, Errasti AE, Rey-Ares V, Rogines-Velo MP, Rothlin RP.

Acta Pharmacol Sin. 2000 Feb;21(2):105-10.

20.

Further pharmacological characterization of bradykinin B1 receptor up-regulation in human umbilical vein.

Sardi SP, Daray FM, Errasti AE, Pelorosso FG, Pujol-Lereis VA, Rey-Ares V, Rogines-Velo MP, Rothlin RP.

J Pharmacol Exp Ther. 1999 Sep;290(3):1019-25.

PMID:
10454473
21.

Characterization of alpha1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein.

Errasti AE, Velo MP, Torres RM, Sardi SP, Rothlin RP.

Br J Pharmacol. 1999 Jan;126(2):437-42.

22.

Bradykinin B1 receptors in human umbilical vein: pharmacological evidence of up-regulation, and induction by interleukin-1 beta.

Sardi SP, Ares VR, Errasti AE, Rothlin RP.

Eur J Pharmacol. 1998 Oct 9;358(3):221-7.

PMID:
9822888

Supplemental Content

Loading ...
Support Center